Targeting death receptors in cancer with Apo2L/TRAIL.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.COPH.2004.02.006PMID 15251125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of TRAIL and its receptors in viral hepatitis

  2003cited by this paper
• Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.

  2003cited by this paper
• Respiratory Syncytial Virus Infection Sensitizes Cells to Apoptosis Mediated by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

  2003cited by this paper
• Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy

  2003cited by this paper
• Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor‐related apoptosis‐inducing ligand

  2003cited by this paper
• Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor‐related apoptosis‐inducing ligand‐induced caspase‐8 activation, apoptosis and loss of mitochondrial membrane potential

  2003cited by this paper
• Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition

  2003cited by this paper
• Synergistic cytotoxic effect of TRAIL and gemcitabine in pancreatic cancer cells.

  2003cited by this paper
• Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.

  2003cited by this paper
• Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation

  2003cited by this paper
• Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.

  2003cited by this paper
• Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)*

  2003cited by this paper
• Nature's TRAIL--on a path to cancer immunotherapy.

  2003cited by this paper
• Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis.

  2003cited by this paper
• Apoptosis induction in renal cell carcinoma by TRAIL and γ-radiation is impaired by deficient caspase-9 cleavage

  2003cited by this paper
• Normal Thymocyte Negative Selection in TRAIL-deficient Mice

  2003cited by this paper
• A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents

  2003cited by this paper
• Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.

  2003cited by this paper
• Apo2L/TRAIL and its death and decoy receptors

  2003cited by this paper
• Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice

  2003cited by this paper
• Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination in Vitro *

  2002cited by this paper
• Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax

  2002cited by this paper
• Targeting death and decoy receptors of the tumour-necrosis factor superfamily

  2002cited by this paper
• Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.

  2002cited by this paper
• Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).

  2002cited by this paper
• TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

  2002cited by this paper
• Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1

  2002cited by this paper
• Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

  2002cited by this paper
• Caspases and apoptosis.

  2002cited by this paper
• TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications.

  2001cited by this paper
• Avoiding premature apoptosis of normal epidermal cells

  2001cited by this paper
• Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.

  2001cited by this paper
• Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

  2001cited by this paper
• Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis1

  2001cited by this paper
• Inhibition of TRAIL-Induced Apoptosis and Forced Internalization of TRAIL Receptor 1 by Adenovirus Proteins

  2001cited by this paper
• Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

  2001cited by this paper
• Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety.

  2001cited by this paper
• Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression

  2000cited by this paper
• Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy.

  2000cited by this paper
• Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

  2000cited by this paper
• A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL.

  2000cited by this paper
• Cysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAIL*

  2000cited by this paper
• Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis.

  2000cited by this paper
• Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

  1999cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Inhibition of fas death signals by FLIPs.

  1998cited by this paper
• Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family*

  1996cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper

• Synergistic Enhancement of Apo2L/TRAIL and DR4-Induced Apoptosis by Arsenic Trioxide in Triple-Negative Breast Cancer Cells: A Comparison to Conventional Chemotherapy

  2025cites this paper
• The characterization of adipose tissue in distinct anatomical regions of the Kazakh horse: a comprehensive analysis of the morphology, fatty acid profile, and lipidomic profile

  2025cites this paper
• A Narrative Review on Breast Cancer Treatment Supported by Focused and Systemic Phytotherapy

  2025cites this paper
• Soluble B7 and TNF family in colorectal cancer: Serum level, prognostic and treatment value.

  2025cites this paper
• Chemical synthetic approaches to mimic the TRAIL: promising cancer therapeutics.

  2024cites this paper
• Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis.

  2024cites this paper
• Daurisoline inhibits proliferation, induces apoptosis, and enhances TRAIL sensitivity of breast cancer cells by upregulating DR5

  2024cites this paper
• SH003 Induces DR5-Mediated Caspase-Dependent Apoptosis of NSCLC Through Inhibition of AKT Survival Pathway

  2024cites this paper
• Investigation of the effects of bicalutamide and TRAIL signaling mechanism on docetaxel resistant prostate cancer cells

  2022cites this paper
• Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression

  2022cites this paper
• TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems

  2022cites this paper
• Cytotoxicity, Apoptosis, Migration Inhibition, and Autophagy-Induced by Crude Ricin from Ricinus communis Seeds in A549 Lung Cancer Cell Lines

  2022cites this paper
• A Missing Hallmark of Cancer: Dysregulation of Differentiation

  2022cites this paper
• The combination of TRAIL and the Smac mimetic LCL-161 induces an irreversible phenotypic change of MCF-7 breast cancer cells.

  2022cites this paper
• Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers

  2022cites this paper
• Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics: Involvement of RIP1 and cFLIP

  2022cites this paper
• Curcumin Sensitises Cancerous Kidney Cells to TRAIL Induced Apoptosis via Let-7C Mediated Deregulation of Cell Cycle Proteins and Cellular Metabolism

  2022cites this paper
• Human Umbilical Cord MSC Delivered-Soluble TRAIL Inhibits the Proliferation and Promotes Apoptosis of B-ALL Cell In Vitro and In Vivo

  2022cites this paper
• Apoptotic Pathway

  2021cites this paper
• Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling

  2021cites this paper
• New Succinimides with Potent Anticancer Activity: Synthesis, Activation of Stress Signaling Pathways and Characterization of Apoptosis in Leukemia and Cervical Cancer Cells

  2021cites this paper
• Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A

  2021cites this paper
• Effects of Curcumin Analogues DMC and EF24 in Combination with the Cytokine TRAIL against Kidney Cancer

  2021cites this paper
• 20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cells

  2021cites this paper
• A375 melanoma cells are sensitized to cisplatin-induced toxicity by a synthetic nitro-flavone derivative 2-(4-Nitrophenyl)-4H-chromen-4-one through inhibition of PARP1

  2021cites this paper
• Trichostatin A and Zebularine along with E-cadherin re-expression enhance tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell cycle arrest in human breast adenocarcinoma cells

  2021cites this paper
• Induction of interferon-β and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells

  2021cites this paper
• Nongenetic engineering strategies for regulating receptor oligomerization in living cells.

  2020cites this paper
• YIPF2 promotes chemotherapeutic agent-mediated apoptosis via enhancing TNFRSF10B recycling to plasma membrane in non-small cell lung cancer cells

  2020cites this paper
• Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells

  2020cites this paper
• TRAIL receptor signaling: From the basics of canonical signal transduction toward its entanglement with ER stress and the unfolded protein response.

  2020cites this paper
• Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms

  2020cites this paper
• CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis.

  2019cites this paper
• Novel Targeted Treatment Approaches in Pancreatic Cancer

  2019cites this paper
• Therapeutic Perspectives of Molecules from Urtica dioica Extracts for Cancer Treatment

  2019cites this paper
• MESENCHYMAL STEM CELLS AS AN ATTRACTIVE CANDIDATE FOR EX–VIVO GENE TRANSFER AND REGENERATIVE CELL THERAPY

  2019cites this paper
• Prediction of genes and protein-protein interaction networking for miR-221-5p using bioinformatics analysis

  2019cites this paper
• Countering TRAIL Resistance in Melanoma

  2019cites this paper
• Engineered human mesenchymal stem cells for neuroblastoma therapeutics

  2019cites this paper
• Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis

  2019cites this paper
• Duloxetine Enhances TRAIL-mediated Apoptosis via AMPK-mediated Inhibition of Autophagy Flux in Lung Cancer Cells

  2019cites this paper
• A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer.

  2019cites this paper
• The TRAIL to cancer therapy: Hindrances and potential solutions.

  2019cites this paper
• Luteolin sensitizes human liver cancer cells to TRAIL‑induced apoptosis via autophagy and JNK‑mediated death receptor 5 upregulation.

  2018cites this paper
• Synergistic action of Cisplatin and 9-Phenyl acridine in A375 cells

  2018cites this paper
• Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis

  2018cites this paper
• Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells

  2018cites this paper
• High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumor effect against colon cancer

  2018cites this paper
• Design and synthesis of a luminescent iridium complex-peptide hybrid (IPH) that detects cancer cells and induces their apoptosis.

  2018cites this paper
• Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells

  2018cites this paper
• A novel TRAIL mutant-TRAIL-Mu3 enhances the antitumor effects by the increased affinity and the up-expression of DR5 in pancreatic cancer

  2018cites this paper
• Caspase-8: A Novel Target to Overcome Resistance to Chemotherapy in Glioblastoma

  2018cites this paper
• Cytochrome P450 1B1 promotes cancer cell survival via specificity protein 1 (Sp1)-mediated suppression of death receptor 4

  2018cites this paper
• TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.

  2018cites this paper
• Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation

  2018cites this paper
• TRAIL attenuates sulforaphane‐mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL‐resistant human bladder cancer cells

  2018cites this paper
• Luminescent Iridium Complex-Peptide Hybrids (IPHs) for Therapeutics of Cancer: Design and Synthesis of IPHs for Detection of Cancer Cells and Induction of Their Necrosis-Type Cell Death

  2018cites this paper
• Regulation of Apoptosis in Melanoma Cells: Critical Targets for Therapeutic Strategies

  2017cites this paper
• University of Groningen Trail receptor-targeted therapy : strategies to enhance DR 4-and DR 5-induced apoptosis

  2017influential citation
• Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.

  2017cites this paper
• Marine actinomycete crude extracts with potent TRAIL-resistance overcoming activity against breast cancer cells.

  2017cites this paper
• TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data.

  2017influential citation
• Bcl-2 Proteins and TRAIL Resistance in Melanoma

  2017cites this paper
• Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.

  2017cites this paper
• HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression

  2017cites this paper
• Fn 14 $ TRAIL fusion protein is oligomerized by TWEAK into a superef fi cient TRAIL analog

  2017cites this paper
• I mmunotherapy, M onoclonals, and V accines Chemotherapeutic Approaches for Targeting Cell Death Pathways

  2017cites this paper
• Identification, characterization and bioactivity of tumor necrosis factor (TNF)‐related apoptosis‐inducing ligand from Equus caballus

  2017cites this paper
• Cell Mechanosensors and the Possibilities of Using Magnetic Nanoparticles to Study Them and to Modify Cell Fate

  2017cites this paper
• Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms

  2017cites this paper
• Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5

  2017cites this paper
• Tumor-homing Stem Cell Therapy for Brain Cancer

  2017cites this paper
• Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?

  2016cites this paper
• Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma

  2016cites this paper
• Onto better TRAILs for cancer treatment

  2016cites this paper
• Chitosan Nanoplexes For Target siRNA Delivery

  2016cites this paper
• High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.

  2016cites this paper
• Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia

  2016influential citation
• SHetA2, a New Cancer-Preventive Drug Candidate

  2016cites this paper
• Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer.

  2016cites this paper
• Characterization of TRAIL-mediated apoptotic pathways in the lung cancer cell line NCI-H460 with focus on caspase-3 and XIAP

  2016cites this paper
• Cancer Genetics in the Clinic

  2016cites this paper
• Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway.

  2016cites this paper
• Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model

  2016cites this paper
• Use of genetically engineered stem cells for glioma therapy.

  2016cites this paper
• The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation

  2015cites this paper
• Tumor necrosis factor-related apoptosis inducing ligand (TRAIL), a member of the TNF family, is a potential cancer agent due to its tumor-specific induction of apoptosis and human recombinant TRAIL is being tested in clinical trials

  2015cites this paper
• Investigating the oncogenic function of FUBP1 in glioblastoma cell lines

  2015cites this paper
• Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage

  2015cites this paper
• Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab

  2015cites this paper
• Insights into the molecular mechanisms of apoptosis induced by glucose deprivation

  2015cites this paper
• Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.

  2015cites this paper
• Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.

  2015cites this paper
• Mesenchymal stromal cells in malignant glioma - Functions and therapeutic potential

  2015cites this paper
• The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5

  2015cites this paper
• Investigating the Oncogenic Function of FUBP 1 in Glioblastoma Cell Lines

  2015cites this paper
• Anticancer activity of NOB 1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells

  2015cites this paper
• TRAIL and targeting cancer cells: between promises and obstacles.

  2015cites this paper
• Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells.

  2015cites this paper
• The Role of Selected Flavonols in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor–1 (TRAIL-R1) Expression on Activated RAW 264.7 Macrophages

  2015cites this paper